Form 4: Neogenomics Director Stephen M. Kanovsky Exercises Stock Options and Acquires Shares

Director Stephen M. Kanovsky exercised stock options and acquired shares of Neogenomics Inc. on August 10, 2024.

Summary

• On August 10, 2024, Stephen M. Kanovsky, a director of Neogenomics Inc., executed transactions involving the company's stock.
• Kanovsky exercised restricted stock units, acquiring 11,336 shares of common stock at a price of $0.
• Following the reported transaction, Kanovsky directly owns 36,090 shares of Neogenomics Inc.
• Kanovsky also holds various stock options with different exercise prices and expiration dates, including options to buy 4,269 shares at $22.52, 3,448 shares at $28.54, 3,714 shares at $40.9, 13,882 shares at $8.1, 8,353 shares at $14.82 and 8,672 shares at $13.71.
• Additionally, Kanovsky holds restricted stock units for 12,254 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions by a company director. It doesn't inherently indicate positive or negative performance for the company.

Positives

• The exercise of stock options and acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect broader industry trends.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company insider.

Key Dates